Advertisement

Risk of Transferring Malignant Cells with Transplanted Frozen-Thawed Ovarian Tissue

  • Marie-Madeleine DolmansEmail author
  • Michelle Soares
Chapter
  • 555 Downloads

Abstract

Although ovarian tissue cryopreservation and transplantation have emerged as a real option to preserve and restore fertility in young cancer patients, there is a legitimate concern regarding the possible presence of malignant cells in the ovarian tissue, which could lead to recurrence of the disease after reimplantation. The present chapter reviews the existing literature on the subject to evaluate the risk of transplanting malignant cells in case of the main malignant indications for ovarian tissue cryopreservation.

Keywords

Ovarian tissue cryopreservation Ovarian tissue transplantation Cancer Risks Malignant cells 

Notes

Acknowledgments

The authors thank Mira Hryniuk, B.A., for reviewing the English language of the manuscript.

References

  1. 1.
    Donnez J, Dolmans MM (2013) Fertility preservation in women. Nat Rev Endocrinol 9:735–749CrossRefPubMedGoogle Scholar
  2. 2.
    Donnez J, Dolmans MM (2014) Transplantation of ovarian tissue. Best Pract Res Clin Obstet Gynaecol 28:1188–1197CrossRefPubMedGoogle Scholar
  3. 3.
    Donnez J, Dolmans MM (2015) Ovarian tissue freezing: current status. Curr Opin Obstet Gynecol 27:222–230CrossRefPubMedGoogle Scholar
  4. 4.
    Dolmans MM, Luyckx V, Donnez J, Andersen CY, Greve T (2013) Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue. Fertil Steril 99:1514–1522CrossRefPubMedGoogle Scholar
  5. 5.
    Dolmans MM, Jadoul P, Gilliaux S, Amorim AC, Luyckx V, Squifflet J, Donnez J, Van Langendonckt A (2013) A review of 15 years of ovarian tissue bank activities. J Assist Reprod Genet 30:305–314CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra’anani H, Slyusarevsky E, Amariglio N, Schiff E, Rechavi G, Nagler A, Yehuda B (2008) Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod 23:1007–1013CrossRefPubMedGoogle Scholar
  7. 7.
    Kyono K, Doshida M, Toya M, Sato Y, Akahira J, Sasano H (2010) Potential indications for ovarian autotransplantation based on the analysis of 5571 autopsy finding of females under the age of 40 in Japan. Fertil Steril 93:2429–2430CrossRefPubMedGoogle Scholar
  8. 8.
    Dolmans MM, Marinescu C, Saussoy P, Van LA, Amorim C, Donnez J (2010) Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood 116:2908–2914CrossRefPubMedGoogle Scholar
  9. 9.
    Rosendahl M, Andersen MT, Ralfkiaer E, Kjeldsen L, Andersen MK, Andersen CY (2010) Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia. Fertil Steril 94:2186–2190CrossRefPubMedGoogle Scholar
  10. 10.
    Rosendahl M, Greve T, Andersen CY (2013) The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. J Assist Reprod Genet 30:11–24CrossRefPubMedGoogle Scholar
  11. 11.
    Greve T, Clasen-Linde E, Andersen MT, Andersen MK, Rosendahl M, Ralfkiaer E, Yding Andersen C (2012) No signs of viable malignant cells in frozen-thawed ovarian cortex intended for fertility preservation from patients with leukaemia. Blood 120:4311–4316CrossRefPubMedGoogle Scholar
  12. 12.
    Dolmans MM (2012) Safety of ovarian autotransplantation. Blood 120:4275–4276CrossRefPubMedGoogle Scholar
  13. 13.
    Jahnukainen K, Tinkanen H, Wikström A, Dunkel L, Saarinen-Pihkala UM, Mäkinen S, Asadi Azarbaijani B, Oskam IC, Vettenranta K, Laine T, Kairisto V, Juvonen V (2012) Bone marrow remission status predicts leukemia contamination in ovarian biopsies collected for fertility preservation. Leukemia 27:1183–1185CrossRefPubMedGoogle Scholar
  14. 14.
    Andolina JR, Neudorf SM, Corey SJ (2012) How I treat childhood CML. Blood 119:1821–1830CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Goldman JM (2007) How I treat chronic myeloid leukemia in the imatinib era. Blood 110:2828–2837CrossRefPubMedGoogle Scholar
  16. 16.
    Pye SM, Cortes J, Ault P, Hatfield A, Kantarjian H, Pilot R, Rosti G, Apperley JF (2008) The effects of imatinib on pregnancy outcome. Blood 15(111):5505–5508CrossRefGoogle Scholar
  17. 17.
    Donnez J, Dolmans MM (2011) Preservation of fertility in females with haematological malignancy. Br J Haematol 154:175–184CrossRefPubMedGoogle Scholar
  18. 18.
    Meirow D, Ben Yehuda D, Prus D et al (1998) Ovarian tissue banking in patients with Hodgkin’s disease: is it safe? Fertil Steril 69:996–998CrossRefPubMedGoogle Scholar
  19. 19.
    Kim SS, Radford J, Harris M et al (2001) Ovarian tissue harvested from lymphoma patients to preserve fertility may be safe for autotransplantation. Hum Reprod 16:2056–2060CrossRefPubMedGoogle Scholar
  20. 20.
    Seshadri T, Gook D, Lade S et al (2006) Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield. Br J Cancer 94:1007–1010CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Bittinger SE, Nazaretian SP, Good DA, Parmar C, Harrup RA, Stern CJ (2011) Detection of Hodgkin lymphoma within ovarian tissue. Fertil Steril 95:803.e3–6Google Scholar
  22. 22.
    Donnez J, Silber S, Andersen CY, Demeestere I, Piver P, Meirow D, Pellicer A, Dolmans MM (2011) Children born after autotransplantation of cryopreserved ovarian tissue. A review of 13 live births. Ann Med 43:437–450CrossRefPubMedGoogle Scholar
  23. 23.
    Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A (2004) Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 364:1405–1410CrossRefPubMedGoogle Scholar
  24. 24.
    Akar ME, Carrillo AJ, Jennell JL, Yalcinkaya TM (2011) Robotic assisted laparoscopic ovarian tissue transplantation. Fertil Steril 95:1120–1128CrossRefPubMedGoogle Scholar
  25. 25.
    Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Zalel Y et al (2005) Pregnancy after transplantation of cryopreserved ovarian tissue in a patient with ovarian failure after chemotherapy. N Engl J Med 353:318–321CrossRefPubMedGoogle Scholar
  26. 26.
    Meirow D, Baum M, Yaron R, Levron J, Hardan I, Schiff E et al (2007) Ovarian tissue cryopreservation in hematologic malignancy: ten years’ experience. Leuk Lymphoma 48:1569–1576CrossRefPubMedGoogle Scholar
  27. 27.
    Stern CJ, Toledo MG, Hale LG, Gook DA, Edgar DH (2011) The first Australian experience of heterotopic grafting of cryopreserved ovarian tissue: evidence of establishment of normal ovarian function. Aust N Z J Obstet Gynaecol 51:268–275CrossRefPubMedGoogle Scholar
  28. 28.
    Tryde Schmidt KL, Yding AC, Starup J, Loft A, Byskov AG, Nyboe AA (2004) Orthotopic autotransplantation of cryopreserved ovarian tissue to a woman cured of cancer—follicular growth, steroid production and oocyte retrieval. Reprod BioMed Online 8:448–453CrossRefPubMedGoogle Scholar
  29. 29.
    Schmidt KT, Rosendahl M, Ernst E, Loft A, Andersen AN, Dueholm M et al (2011) Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure: the Danish experience. Fertil Steril 95:695–701CrossRefPubMedGoogle Scholar
  30. 30.
    Andersen CY, Rosendahl M, Byskov AG et al (2008) Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod 23:2266–2272CrossRefPubMedGoogle Scholar
  31. 31.
    Azem F, Hasson J, Ben-Yosef D, Kossoy N, Cohen T, Almog B, Amit A, Lessing JB, Lifschitz-Mercer B (2010) Histologic evaluation of fresh human ovarian tissue before cryopreservation. Int J Gynecol Pathol 29:19–23CrossRefPubMedGoogle Scholar
  32. 32.
    Perrotin F, Marret H, Bouquin R, Fischer-Perrotin N, Lansac J, Body G (2001) Incidence, diagnosis and prognosis of ovarian metastasis in breast cancer. Gynecol Obstet Fertil 29:308–315CrossRefPubMedGoogle Scholar
  33. 33.
    Gagnon Y, Têtu B (1989) Ovarian metastases of breast carcinoma. A clinicopathologic study of 59 cases. Cancer 64:892–898CrossRefPubMedGoogle Scholar
  34. 34.
    Sánchez-Serrano M, Novella-Maestre E, Roselló-Sastre E, Camarasa N, Teruel J, Pellicer A (2009) Malignant cells are not found in ovarian cortex from breast cancer patients undergoing ovarian cortex cryopreservation. Hum Reprod 24:2238–2243CrossRefPubMedGoogle Scholar
  35. 35.
    Rosendahl M, Timmermans Wielenga V, Nedergaard L, Kristensen SG, Ernst E, Rasmussen PE, Anderson M, Schmidt KT, Andersen CY (2011) Cryopreservation of ovarian tissue for fertility preservation: no evidence of malignant cell contamination in ovarian tissue from patients with breast cancer. Fertil Steril 95:2158–2161CrossRefPubMedGoogle Scholar
  36. 36.
    Luyckx V, Durant JF, Camboni A, Gilliaux S, Amorim CA, Van Langendonckt A, Irenge LM, Gala JL, Donnez J, Dolmans MM (2013) Is transplantation of cryopreserved ovarian tissue from patients with advanced-stage breast cancer safe? A pilot study. J Assist Reprod Genet 30:1289–1299CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Bockstaele L, Boulenouar S, Van Den Steen G, Dechène J, Tsepelidis S, Craciun L, Noël JC, Demeestere I (2015) Evaluation of quantitative polymerase chain reaction markers for the detection of breast cancer cells in ovarian tissue stored for fertility preservation. Fertil Steril 104(2):410–417Google Scholar
  38. 38.
    Morice P, Haie-Meder C, Pautier P, Lhomme C, Castaigne D (2001) Ovarian metastasis on transposed ovary in patients treated for squamous cell carcinoma of the uterine cervix: report of two cases and surgical implications. Gynecol Oncol 83:605–607CrossRefPubMedGoogle Scholar
  39. 39.
    Nakanishi T, Wakai K, Ishikawa H, Nawa A, Suzuki Y, Nakamura S, Kuzuya K (2001) A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol 82:504–509CrossRefPubMedGoogle Scholar
  40. 40.
    Kim SS (2012) Assessment of long term endocrine function after transplantation of frozen-thawed ovarian tissue to the heterotopic site: 10 year longitudinal follow-up study. J Assist Reprod Genet 29:489–493CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Donnez J, Dolmans MM, Pellicer A, Diaz-Garcia C, Sanchez Serrano M, Schmidt KT, Ernst E, Luyckx V, Andersen CY (2013) Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril 99:1503–1513CrossRefPubMedGoogle Scholar
  42. 42.
    Donnez J, Dolmans MM, Pellicer A, Diaz-Garcia C, Ernst E, Macklon KT, Andersen CY (2015) Fertility preservation for age-related fertility decline. Lancet 385:506–507CrossRefPubMedGoogle Scholar
  43. 43.
    Pan Z, Wang X, Zhang X, Chen X, Xie X (2011) Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinoma. J Obstet Gynaecol Res 37:352–358CrossRefPubMedGoogle Scholar
  44. 44.
    Dundar E, Tel N, Ozalp SS, Isiksoy S, Kabukcuoglu S, Bal C (2002) The significance of local cellular immune response of women 50 years of age and younger with endometrial carcinoma. Eur J Gynaecol Oncol 23:243–246PubMedGoogle Scholar
  45. 45.
    Sonmezer M, Oktay K (2004) Fertility preservation in female patients. Hum Reprod Update 10:251–266CrossRefPubMedGoogle Scholar
  46. 46.
    Donnez J, Squifflet J, Jadoul P, Demylle D, Cheron AC, Van Langendonckt A, Dolmans MM (2011) Pregnancy and live birth after autotransplantation of frozen-thawed ovarian tissue in a patient with metastatic disease undergoing chemotherapy and hematopoietic stem cell transplantation. Fertil Steril 95:1787CrossRefPubMedGoogle Scholar
  47. 47.
    Ernst E, Bergholdt S, Jørgensen JS, Andersen CY (2010) The first woman to give birth to two children following transplantation of frozen/thawed ovarian tissue. Hum Reprod 25:1280–1281CrossRefPubMedGoogle Scholar
  48. 48.
    Sørensen SD, Greve T, Wielenga VT, Wallace WH, Andersen CY (2014) Safety considerations for transplanting cryopreserved ovarian tissue to restore fertility in female patients who have recovered from Ewing’s sarcoma. Future Oncol 10:277–283CrossRefPubMedGoogle Scholar
  49. 49.
    Abir R, Feinmesser M, Yaniv I, Fisch B, Cohen IJ, Ben-Haroush A, Meirow D, Felz C, Avigad S (2010) Occasional involvement of the ovary in Ewing sarcoma. Hum Reprod 25:1708–1712CrossRefPubMedGoogle Scholar
  50. 50.
    Poirot CJ, Martelli H, Genestie C, Golmard JL, Valteau-Couanet D, Helardot P, Pacquement H, Sauvat F, Tabone MD et al (2007) Feasibility of ovarian tissue cryopreservation for prepubertal females with cancer. Pediatr Blood Cancer 49:74–78CrossRefPubMedGoogle Scholar
  51. 51.
    Rosendahl M, Schmidt KT, Ernst E, Rasmussen PE, Loft A, Byskov AG, Nyboe Andersen A, Andersen CY (2011) Cryopreservation of ovarian tissue for a decade in Denmark—an overview of the technique. Reprod Med Online 22:162–171CrossRefGoogle Scholar

Copyright information

© Springer Japan 2016

Authors and Affiliations

  1. 1.Pôle de Recherche en Gynécologie, Institut de Recherche Expérimentale et Clinique (IREC)Cliniques Universitaires Saint LucBrusselsBelgium
  2. 2.Département de GynécologieCliniques Universitaires Saint-LucBrusselsBelgium

Personalised recommendations